Menu Search
Equities

Miricor Enterprises Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1827:HKG.HS

Miricor Enterprises Holdings Ltd

Actions
  • Price (HKD)0.71
  • Today's Change0.00 / 0.00%
  • Shares traded40.00k
  • 1 Year change-36.61%
  • Beta0.0969
Data delayed at least 15 minutes, as of Feb 11 2026 07:27 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Miricor Enterprises Holdings Ltd is an investment holding company principally provides medical aesthetic services. The Company is engaged in the non-surgical medical aesthetics and lifestyle beauty business providing treatment services, medical consultation services, prescription and dispensing services. The Company also sells skin care products such as facial cleansers, toners, serums, moisturizers, eye care products, ultraviolet (UV) protection products and facial masks.

  • Revenue in HKD (TTM)363.16m
  • Net income in HKD10.89m
  • Incorporated2016
  • Employees255.00
  • Location
    Miricor Enterprises Holdings Ltd18/F, Nan Fung Tower88 Connaught Road, Central Hong KongHKG
  • Websitehttp://www.miricor.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.